Integrating Exposure and Response Prevention With a Mobile App to Treat Obsessive-Compulsive Disorder: Feasibility, Acceptability, and Preliminary Effects

被引:11
|
作者
Gershkovich, Marina [1 ,2 ]
Middleton, Rachel [1 ,2 ]
Hezel, Dianne M. [1 ,2 ]
Grimaldi, Stephanie [3 ]
Renna, Megan [4 ]
Basaraba, Cale [1 ]
Patel, Sapana [1 ,2 ]
Simpson, H. Blair [1 ,2 ]
机构
[1] New York State Psychiat Inst & Hosp, 1051 Riverside Dr, New York, NY 10025 USA
[2] Columbia Univ, Med Ctr, New York, NY 10027 USA
[3] Hofstra Univ, Hempstead, NY 11550 USA
[4] Ohio State Univ, Coll Med, Columbus, OH 43210 USA
关键词
cognitive-behavioral therapy; treatment; OCD; mobile app; technology; COGNITIVE-BEHAVIORAL THERAPY; CONTROLLED-TRIAL; SELF-HELP; METAANALYSIS; SCALE; INTERVENTIONS; REMISSION; ANXIETY;
D O I
10.1016/j.beth.2020.05.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Many individuals with obsessive-compulsive disorder (OCD) do not receive evidence-based care (specifically exposure and ritual prevention; EX/RP) due to barriers such as a lack of EX/RP-trained clinicians, geographic obstacles, and the cost and time associated with the treatment. Offering an integrated treatment model consisting of brief in-person therapy coupled with a mobile application (app) might be one way to increase access to and reduce the time burden (to clinicians and patients) of EX/RP. This pilot trial evaluated the feasibility, acceptability, and clinical effects of such a treatment program for adults with OCD. Thirty-three participants enrolled in the 8-week open trial. The integrated treatment program consisted of 3 to 5 in-person sessions followed by weekly phone calls supported by a mobile app (nOCD). Participants were evaluated by trained raters and completed self-report measures at baseline, midtreatment, posttreatment and 2-month follow-up; the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) was the primary outcome. This integrated treatment program was feasible and acceptable to participants. Of the 33 study entrants, 14 (42%) responded to treatment (Y-BOCS decrease >= 35% with CGI- of 1 or 2), and 8 (24%) achieved minimal symptoms (i.e., Y-BOCS <= 12). At 2-month follow-up (n=20), 7/20 (35%) met criteria for treatment response, and 3/20 (15.0%) met criteria for treatment remission. Although preliminary, this model warrants further study as an efficacious and resource-efficient way to deliver EX/RP for some patients with OCD.
引用
收藏
页码:394 / 405
页数:12
相关论文
共 50 条
  • [41] Exposure and Response Prevention Helps Adults With Obsessive-Compulsive Disorder Who Do Not Respond to Pharmacological Augmentation Strategies
    McLean, Carmen P.
    Zandberg, Laurie J.
    Van Meter, Page E.
    Carpenter, Joseph K.
    Simpson, Helen Blair
    Foa, Edna B.
    JOURNAL OF CLINICAL PSYCHIATRY, 2015, 76 (12) : 1653 - 1657
  • [42] Impact of the COVID-19 pandemic on exposure and response prevention outcomes in adults and youth with obsessive-compulsive disorder
    Storch, Eric A.
    Sheu, Jessica C.
    Guzick, Andrew G.
    Schneider, Sophie C.
    Cepeda, Sandra L.
    Rombado, Bianca R.
    Gupta, Rohit
    Hoch, Connor T.
    Goodman, Wayne K.
    PSYCHIATRY RESEARCH, 2021, 295
  • [43] Exposure and Response Prevention as an Evidence-Based Treatment for Obsessive-Compulsive Disorder: Considerations for Social Work Practice
    Bornheimer, Lindsay A.
    CLINICAL SOCIAL WORK JOURNAL, 2015, 43 (01) : 38 - 49
  • [44] A thematic analysis of barriers and facilitators to participant engagement in group exposure and response prevention therapy for obsessive-compulsive disorder
    Leeuwerik, Tamara
    Caradonna, Giorgia
    Cavanagh, Kate
    Forrester, Elizabeth
    Jones, Anna-Marie
    Lea, Laura
    Rosten, Claire
    Strauss, Clara
    PSYCHOLOGY AND PSYCHOTHERAPY-THEORY RESEARCH AND PRACTICE, 2023, 96 (01) : 129 - 147
  • [45] The effectiveness of exposure and response prevention combined with pharmacotherapy for obsessive-compulsive disorder: A systematic review and meta-analysis
    Mao, Lingyun
    Hu, Maorong
    Luo, Lan
    Wu, Yunhong
    Lu, Zihang
    Zou, Jingzhi
    FRONTIERS IN PSYCHIATRY, 2022, 13
  • [46] Combination of ketamine and esketamine with Exposure and Response Prevention (ERP) therapy for Obsessive-Compulsive Disorder
    Bottemanne, Hugo
    Arnould, Alice
    Najar, Amaury
    Delaigue, Fanny
    Serresse, Laure
    Joly, Lucie
    Mouchabac, Stephane
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2023, 49 (03): : 304 - 311
  • [47] Treatment expectancy and credibility as predictors of concentrated exposure treatment outcomes in patients with difficult-to-treat obsessive-compulsive disorder
    Berg, Havard
    Tjelle, Kristian
    Hansen, Bjarne
    Solem, Stian
    Bjorgvinsson, Throestur
    Kvale, Gerd
    Hagen, Kristen
    BMC PSYCHIATRY, 2025, 25 (01)
  • [48] A pilot open trial of video telehealth-delivered exposure and response prevention for obsessive-compulsive disorder in rural Veterans
    Fletcher, Terri L.
    Boykin, Derrecka M.
    Helm, Ashley
    Dawson, Darius B.
    Ecker, Anthony H.
    Freshour, Jessica
    Teng, Ellen
    Lindsay, Jan
    Hundt, Natalie E.
    MILITARY PSYCHOLOGY, 2022, 34 (01) : 83 - 90
  • [49] Relationships between obsessive-compulsive disorder, depression and functioning before and after exposure and response prevention therapy
    Motivala, Sarosh J.
    Arellano, Maria
    Greco, Rebecca L.
    Aitken, David
    Hutcheson, Nathan
    Tadayonnejad, Reza
    O'Neill, Joseph
    Feusner, Jamie D.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2018, 22 (01) : 40 - 46
  • [50] The effectiveness of metacognitive therapy in comparison to exposure and response prevention for obsessive-compulsive disorder: A randomized controlled trial
    Melchior, Kim
    van der Heiden, Colin
    Deen, Mathijs
    Mayer, Birgit
    Franken, Ingmar H. A.
    JOURNAL OF OBSESSIVE-COMPULSIVE AND RELATED DISORDERS, 2023, 36